tiprankstipranks
Celon Pharma SA (PL:CLN)
:CLN
Poland Market
CLN
Celon Pharma SA
RESEARCH TOOLSreports
Want to see PL:CLN full AI Analyst Report?

Celon Pharma SA (CLN) Financial Statements

0 Followers

Celon Pharma SA Financial Overview

Celon Pharma SA's market cap is currently zł1.15B. The company's EPS TTM is zł; its P/E ratio is -13.81; and it has a dividend yield of 0.43%. Celon Pharma SA is scheduled to report earnings on April 22, 2026, and the estimated EPS forecast is zł―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenuezł 209.80Mzł 176.62Mzł 213.92Mzł 161.91Mzł 196.09M
Gross Profitzł -39.48Mzł 113.45Mzł 147.10Mzł 95.45Mzł 134.37M
Operating Incomezł -56.76Mzł -36.81Mzł -27.24Mzł -69.76Mzł -10.45M
EBITDAzł -10.48Mzł 14.96Mzł 32.71Mzł 9.32Mzł 27.81M
Net Incomezł -79.36Mzł -34.45Mzł -28.12Mzł -39.28Mzł -11.61M
Balance Sheet
Cash & Short-Term Investmentszł 19.91Mzł 56.52Mzł 114.54Mzł 164.62Mzł 227.55M
Total Assetszł 457.46Mzł 543.79Mzł 569.31Mzł 608.93Mzł 707.14M
Total Debtzł 18.94Mzł 16.93Mzł 25.59Mzł 26.82Mzł 14.92M
Net Debtzł -367.00Kzł 8.65Mzł -6.77Mzł -56.08Mzł -132.88M
Total Liabilitieszł 74.47Mzł 98.59Mzł 123.75Mzł 129.29Mzł 153.14M
Stockholders' Equityzł 363.25Mzł 445.21Mzł 445.56Mzł 479.65Mzł 554.00M
Cash Flow
Free Cash Flowzł -30.57Mzł -34.13Mzł -41.13Mzł -38.61Mzł 2.60M
Operating Cash Flowzł 23.86Mzł -11.34Mzł -8.31Mzł -4.70Mzł 43.95M
Investing Cash Flowzł -21.64Mzł -7.49Mzł -21.64Mzł -31.47Mzł -121.05M
Financing Cash Flowzł -9.76Mzł 13.32Mzł -20.59Mzł -28.72Mzł 180.91M
Currency in PLN

Celon Pharma SA Earnings and Revenue History

Income Statement >

Celon Pharma SA Debt to Assets

Balance Sheet >

Celon Pharma SA Cash Flow

Cash Flow >

Celon Pharma SA Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >